Key facts
- Notable investors include Hongfeng Capital, Kangjun Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for EClinCloud
- ·The full record, as it builds
Funding rounds
No funding rounds for EClinCloud are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EClinCloud
Developer of a clinical cloud platform designed for new drug development. The company develops an end-to-end seamless integration platform for new drug development, enabling pharmaceutical enterprises, medical device companies, and research institutions to accelerate the drug development process, lower the clinical research cost, and reduce the clinical research risk.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Website
- eclincloud.com/
- Ownership
- Privately Held (backing)
EClinCloud doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EClinCloud shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EClinCloud in its N-PORT filings yet. We sweep new filings monthly.